Skip to content
Governance Register

← US public companies

Design Therapeutics, Inc.

SEC CIK 1807120 · DSGN · last insider filing 2026-06-11

Directors (from insider filings)

NameCapacity as filedFilings
Schmid John P. Director filed 2021 - 2026
Shapiro David Director filed 2026 - 2026
Lappe Rodney W Director filed 2021 - 2026
George Simeon Director filed 2021 - 2026
Berger Heather A. Director filed 2021 - 2026
Gover Justin D. Director filed 2025 - 2026
Shah Pratik Director · President, CEO and Chairperson filed 2021 - 2026
William Arsani Director filed 2021 - 2025
Prasad Deepa Director filed 2021 - 2025
Xu Stella Director filed 2021 - 2023
Siffert Joao MD Director · President and CEO filed 2021 - 2023
Chen Bihua Director filed 2021 - 2021

Officers (from insider filings)

NameTitle as filedFilings
Storgard Chris Chief Medical Officer filed 2025 - 2026
Jeffries Sean Chief Operating Officer filed 2021 - 2026
Burgess Julie Chief Accounting Officer filed 2021 - 2026
Kim Jae B. Chief Medical Officer filed 2024 - 2024
Giangiulio Dawn Principal Accounting Officer filed 2021 - 2021
Thacker Justin Vice President, Finance filed 2021 - 2021

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.